Cargando…

Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with type 2 diabetes

INTRODUCTION: The present phase 3, randomized, open‐label study compared the efficacy and safety of basal insulin peglispro with insulin glargine after 26 weeks of treatment when added to oral antihyperglycemic medications in insulin‐naïve Asian patients with type 2 diabetes. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Takahisa, Cai, Zhihong, Yeo, Kwee Poo, Imori, Makoto, Ohwaki, Kenji, Imaoka, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754544/
https://www.ncbi.nlm.nih.gov/pubmed/28371567
http://dx.doi.org/10.1111/jdi.12667